The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status
Top Cited Papers
- 31 July 2004
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 165 (1), 107-113
- https://doi.org/10.1016/s0002-9440(10)63279-8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA84967, CA85129)
- Howard Hughes Medical Institute (CA84967, CA85129)
This publication has 24 references indexed in Scilit:
- Exploring the Host Desmoplastic Response to Pancreatic Carcinoma: Gene Expression of Stromal and Neoplastic Cells at the Site of Primary InvasionThe American Journal of Pathology, 2002
- Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical EndpointsThe American Journal of Pathology, 2001
- Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile.2001
- KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.2001
- Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I studyThe Lancet, 2001
- Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networksNature Medicine, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorThe New England Journal of Medicine, 2001
- Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumoursThe Journal of Pathology, 2001
- Gastrointestinal Stromal Tumor Versus Intra-abdominal Fibromatosis of the Bowel WallThe American Journal of Surgical Pathology, 2000
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998